Myeloma cells express BMP-2 and Wnt antagonists: A mechanism of impaired bone formation in multiple myeloma.

被引：0
|
作者：
Oshima, T
Abe, M
Hashimoto, T
Shibata, H
Sekimoto, E
Tanaka, T
Kitazoe, K
Hara, T
Ozaki, S
Kido, S
Inoue, D
Matsumoto, T
Kosaka, M
机构：
[1] Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 770, Japan
[2] Tokushima Univ Hosp, Div Transfus Med, Tokushima, Japan
[3] Tokushima Prefectural Hosp, Dept Internal Med, Kaifu, Japan
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3461
引用
收藏
页码：930A / 930A
页数：1
相关论文
共 50 条
  • [1] Myeloma cells express BMP-2 and Wnt antagonists: A mechanism of impaired bone formation in multiple myeloma
    Oshima, T
    Abe, N
    Hashimoto, T
    Shibata, H
    Sekimoto, E
    Tanaka, Y
    Kitazoe, K
    Hara, T
    Ozaki, S
    Kido, S
    Inoue, D
    Matsumoto, T
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1581 - 1581
  • [2] Myeloma cells suppress BMP-2-mediated osteoblast differentiation: Impaired bone formation in multiple myeloma.
    Oshima, T
    Abe, M
    Hara, T
    Kitazoe, K
    Sekimoto, E
    Tanaka, Y
    Shibata, H
    Hashimoto, T
    Ozaki, S
    Kido, S
    Inoue, D
    Matsumoto, T
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S309 - S309
  • [3] Myeloma cells suppress osteoblast differentiation: Impaired bone formation in multiple myeloma
    Oshima, T
    Abe, M
    Hashimoto, T
    Shibata, H
    Sekimoto, E
    Tanaka, Y
    Ozaki, S
    Kido, S
    Inoue, D
    Matsumoto, T
    [J]. BONE, 2003, 32 (05) : S129 - S129
  • [4] Utilizing BMP-2 muteins for treatment of multiple myeloma
    Seher, Axel
    Lagler, Charlotte
    Stuehmer, Thorsten
    Mueller-Richter, Urs Dietmar Achim
    Kuebler, Alexander Christian
    Sebald, Walter
    Mueller, Thomas Dieter
    Nickel, Joachim
    [J]. PLOS ONE, 2017, 12 (05):
  • [5] Abnormalities of bone marrow mesenchymal stem cells in multiple myeloma.
    Wallace, SR
    Oken, MH
    Van Ness, B
    Masellis, AM
    [J]. BLOOD, 1999, 94 (10) : 547A - 547A
  • [6] HGF inhibits BMP-induced osteoblastogenesis: Implications for the bone disease in multiple myeloma.
    Standal, Therese
    Abildgaard, Niels
    Fagerli, Unn-Merete
    Stordal, Berit
    Hjertner, Oyvind
    Borset, Magne
    Sundan, Anders
    [J]. BLOOD, 2006, 108 (11) : 985A - 985A
  • [7] Expression of RANKL in myeloma cell lines and bone marrow plasma cells in patients with multiple myeloma.
    Sezer, O
    Heider, U
    Jakob, C
    Eucker, J
    Niemöller, K
    Zavrski, I
    Possinger, K
    [J]. BLOOD, 2001, 98 (11) : 304B - 304B
  • [8] Semaphorin 4D to suppress bone formation in multiple myeloma.
    Lantos, Konstantinos
    Adannik, Juraj
    Zhang, Peng
    Sun, Quanhong
    Roodman, David
    Suvannasankha, Attaya
    Galson, Deborah Lynn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Mechanical loading leads to bone formation in vivo in osteolytic Multiple Myeloma.
    Rummler, Maximilian
    Ziouti, Fani
    Seliger, Anne
    Lynch, Maureen
    Franziska, Jundt
    Willie, Bettina
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S327 - S327
  • [10] Myeloma cells decrease EphB4 expression in osteoblasts; A novel mechanism for regulation of bone formation in multiple myeloma
    Bates, A. L.
    Mundy, G. R.
    Edwards, C. M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S87 - S87
12345